Prolight Diagnostics
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.
Prolight secures patent in Japan for Psyros™ technology
Prolight Diagnostics announces today that the company’s patent for the Psyros™ technology for single molecule counting has officially been granted in Japan by the Japan Patent Office (JPO). The patent is valid until 2040.
“This milestone represents another major advancement for the Prolight intellectual property portfolio and enhances the attractiveness of our technology to potential international commercial partners,” said Ulf Bladin, CEO of Prolight.
| Datum | 2025-07-21, kl 08:00 |
| Källa | MFN |